Microsoft has cut its sales targets for its agentic AI software after struggling to find buyers interested in using it. In some cases, targets have been slashed by up to 50%, suggesting Microsoft ...

Since its release in 2009, it's been a continuing fallacy for pundits to hold up Mac OS X Snow Leopard as the perfect example of how Apple should update the Mac. It's a funny world where Apple is ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer discussed, along with the tech battleground. Answering a caller’s query about the stock during the lightning round, Cramer ...

After the White House used a Sabrina Carpenter song without her permission, the pop star is keeping her response short and sweet. The "Espresso" singer, 26, took to X to slam the White House for using ...

Another day, another Nicki Minaj controversy on Twitter. The Grammy Award-winning rapper with a penchant for sharing her unfiltered thoughts on the internet took to her social media platform of choice ...

Google was accused in a lawsuit of using its Gemini AI assistant to unlawfully track the private communications of users of its Gmail, instant messaging and videoconference programs. In the past, ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

What is it with lawyers and AI? We don’t know, but it feels like an inordinate number of them keep screwing up with AI tools, apparently never learning from their colleagues who get publicly crucified ...

“Interviews are NOT real anymore.” So reads the opening caption of a TikTok posted in September, punctuated by the skull-and-crossbones emoji. In the video, a young woman interviews for a job on a ...

AI has transformed my experience of education. I am a senior at a public high school in New York, and these tools are everywhere. I do not want to use them in the way I see other kids my age using ...

Recursion Pharmaceuticals has significantly lagged the market since its 2021 IPO. The company's potentially revolutionary approach has yet to produce results. The stock's upside is enormous if ...